Protein (Article) 9

th
May
500 words
protein that may slow deadly lung disease

New study claims that protein can cut down and reduce the deadly lung disorders
Lung disorders can cause various types of unhealthy issues and among these deadly issues; pulmonary
fibrosis is a medical concern that can source one to have covered with scar tissues. It is seen that with
the disease can hit by causing one to have shortness of breath or breathlessness and medically seen that
the issue gets even worse as it progresses. It is seen that the disease causes development after getting
exposed to the toxic gases and asbestos and at times even the treatment by radiation conducted during
lung cancer can be a major reason for the issue. The unfortunate issue is that one comes to know about
the issue after getting symptoms. By the time the problem gets diagnosed, the issue of permanent form
of scarring might already have caused. The auto immune diseases and the chronic inflammatory cases
can lead to such issues.
The case of pulmonary fibrosis is a type of issue which keeps on progressing and various survey states
that around 5 million populations globally has been affected and only few survived the issue. Not only
the case of survival, the entire issue took more than 3 to 5 years post diagnosis. With the new research
study, it is suggested that the protein molecule can help in slowing down the issue caused by such
chronic cases of lung disorder. Patients if found suffering from issue like high blood level of protein
known as LYCAT, they have better and higher chance of survival along with functioning of lungs than
compared to the patients who are suffering from lower level.
Various other research studies involved that various genes might be involved in the progressing of IPF
(Idiopathic Pulmonary Fibrosis) which is a form of disease that involves zero identification of the causes.
Post this period, medical research investigation involved coding for the protein named LYCAT or
Lysocardiolipin Acyltransferase for the development of the IPF.
LYCAT protein can be used to protect one from against the gradual and slow development and growth of
the pulmonary fibrosis. The LYCAT measuring in the levels in blood of an IPF patient indicated that the
highest levels of significant survival nature post the 3 years of diagnosis had better lung functioning than
the others when compared. The study of LYCAT helped by providing one with a protective layer or the
slow and reduced progress of the disease. It helped in boosting the LYCAT levels in the patients who
were suffering from pulmonary fibrosis which may become viable to the new and latest therapeutic
approach for providing proper treatment. The LYCAT levels and its increasing indicate a latest approach
in treating the issue of lung disorder.
The study of LYCAT involved how the mice were bred to developing of scarring of lung tissue. It was seen
that without the availability of the gene in these mice, the scar tissue had developed in a quicker
manner compared to the other mice with gene. During the lab test it was seen that the scar tissue had
developed even on a slower basis in the mice where were engineered for having a higher than the
normal level of LYCAT.